Rifaximin to Prevent Recurrent HCV-Related Fibrosis After Liver Transplant
Clinical trial NCT01603108 · UNKNOWN
Trial details
- NCT number
- NCT01603108
- Sponsor
- Columbia University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-03-01
- Primary completion
- 2016-12-01
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.